Aaron John Niznick, DPT, ATC Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1564 Route 507, Suite C, Greentown, PA 18426 Phone: 570-676-0700 Fax: 570-676-0766 |
Edward C Desmet Jr., MSPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1564 Route 507, Suite C, Greentown, PA 18426 Phone: 570-676-0700 Fax: 570-676-0766 |
Heather Gaydos, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1564 Route 507 Ste C, Greentown, PA 18426 Phone: 570-676-0700 Fax: 570-676-0766 |
Dr. Caitlin Gregory, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1564 Route 507 Ste C, Greentown, PA 18426 Phone: 570-676-0700 |
Melissa M Gavin, MSPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1564 Route 507, Suite C, Greentown, PA 18426 Phone: 570-676-0700 Fax: 570-676-0766 |
Bella Langan, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1564 Route 507, Suite C, Greentown, PA 18426 Phone: 570-676-0700 Fax: 570-676-0766 |
Alexa Croley, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1564 Route 507 Ste C, Greentown, PA 18426 Phone: 570-676-0700 Fax: 570-676-0766 |
News Archive
Ambit Biosciences, today announced that it has initiated separate Phase I trials for two products AC430, a selective Janus Kinase 2 (JAK2) inhibitor, and AC480, a pan-HER inhibitor.
Remarkable progress in the development of new concepts and techniques used in reconstructive surgery of microtia/atresia of the external auditory canal (EAC) has been made since the beginning of the 21st century.
The latest phase of the campaign aims to raise awareness of the potential dangers of trips and falls in the workplace and features some graphic and hard hitting posters. The posters, typically featuring alarming images of workers 'shattering' upon impact following a fall, also feature safety information targeted at reducing such accidents.
Large, for-profit dialysis facilities appear to administer higher than necessary amounts of a medication for treating anemia in patients with kidney disease, compared to nonprofit facilities, according to a study in the April 18 issue of JAMA.
A new analysis of the TRITON-TIMI 38 study evaluated response rates in patients with a common genetic variant in the ABCB1 gene. Patients enrolled in the TRITON-TIMI 38 study were treated with dual antiplatelet therapy with either Plavix® (clopidogrel) plus aspirin or Effient® (prasugrel) plus aspirin and managed with percutaneous coronary intervention (PCI) following an acute coronary syndrome (ACS) event.
› Verified 1 days ago